ResearcherSichuan UniversityNo recent work listed
Chao Wu
Matched on ORCID iD 0000-0003-0260-2868; OpenAlex author ID A5085239564. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper
Papers 5
- Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single cen… Co-author DOI 10.3389/fonc.2022.966256↗
- EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. Co-author DOI 10.1097/md.0000000000027103↗
- Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer. Co-author DOI 10.1186/s12893-020-00856-y↗
- Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer. Co-author DOI 10.2147/dddt.s261017↗
- Whole Grain Intake Reduces Pancreatic Cancer Risk: A Meta-Analysis of Observational Studies. Co-author DOI 10.1097/md.0000000000002747↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zuowei Wu · 3 shared papers, 2020–2022 · strength 0.50
- Paper Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer. DOI 10.1186/s12893-020-00856-y↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103↗
- Bole Tian · 2 shared papers, 2020–2022 · strength 0.35
- Paper Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer. DOI 10.1186/s12893-020-00856-y↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Xing Huang · 2 shared papers, 2021–2022 · strength 0.31
- Li Mao · 2 shared papers, 2021–2022 · strength 0.31
- Zihe Wang · 2 shared papers, 2021–2022 · strength 0.31
- Li Wang · 2 shared papers, 2020–2022 · strength 0.28
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pan… DOI 10.2147/dddt.s261017↗
- Pengcheng Zhao · 1 shared paper, 2022 · strength 0.16
- Bole Tian · 1 shared paper, 2021 · strength 0.15
- Chen Yang · 1 shared paper, 2020 · strength 0.11
- Yi Zhang · 1 shared paper, 2020 · strength 0.11
- Xing Huang · 1 shared paper, 2020 · strength 0.11
- Bole Tian · 1 shared paper, 2020 · strength 0.11
- Jieshou Li · 1 shared paper, 2016 · strength 0.05
- Qiucheng Lei · 1 shared paper, 2016 · strength 0.05
- Li Zhang · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.